peripheral blood mononuclear cell transcriptomics
Showing 9976 - 10000 of >10,000
Patients Who Received Gene-Modified Cell Therapy
Enrolling by invitation
- Long-term Follow-up
- Gene-Modified Cell Therapy
-
Philadelphia, PennsylvaniaAbramson Cancer Center Clinical Research Unit, University of Pen
Jul 21, 2022
Advanced Malignancies, Non-small-cell Lung Cancer Trial in Worldwide (PF-06801591)
Active, not recruiting
- Advanced Malignancies
- Non-small-cell Lung Cancer
-
Beijing, Beijing, China
- +51 more
Jan 11, 2023
Extensive-stage Small-cell Lung Cancer Trial in Japan, United States (DS-7300a)
Recruiting
- Extensive-stage Small-cell Lung Cancer
- Ifinatamab Deruxtecan (I-DXd)
-
Jacksonville, Florida
- +22 more
Jan 10, 2023
Validation of a Predictive Score of Acute Chest Syndrome
Recruiting
- Vaso Occlusive Crisis
- Acute Chest Syndrome
-
Creteil, FranceHenri Mondor Hospital
Dec 12, 2022
Esophageal Cancer Trial in Moscow (Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.,
Recruiting
- Esophageal Cancer
- Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.
- Patients undergoing neoadjuvant chemotherapy plus Ivory-Lewis or McKeown esophagectomy
-
Moscow, Russian FederationN.N. Blokhin National Medical Research Center of Oncology
Oct 2, 2022
Uterine Myomectomy Trial in Madrid (With temporary occlusion)
Completed
- Uterine Myomectomy
- With temporary occlusion
-
Madrid, SpainEnrique Moratalla Bartolomé
Aug 8, 2023
Ménière's Disease Trial in Munich (Betahistine diHCl, Selegiline-HCl)
Completed
- Ménière's Disease
- Betahistine dihydrochloride
- Selegiline-hydrochloride
-
Munich, Bavaria, GermanyDepartment of Neurology, Ludwig Maximilian University
Jul 10, 2023
Non-Small-Cell Lung Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Placebo Comparator,
Active, not recruiting
- Non-Small-Cell Lung
- Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
- +6 more
-
Tucson, Arizona
- +128 more
Nov 10, 2022
Oxygen Toxicity, Anesthesia; Adverse Effect Trial in Milano (LUS-guided choice of Peep, Standard choice of Peep)
Not yet recruiting
- Oxygen Toxicity
- Anesthesia; Adverse Effect
- LUS-guided choice of Peep
- Standard choice of Peep
-
Milano, ItalyVittore Buzzi Cildren's Hospital
Feb 18, 2023
Gorlin Syndrome Trial (Patidegib Topical Gel, Vehicle Gel)
Not yet recruiting
- Gorlin Syndrome
- Patidegib Topical Gel
- Vehicle Gel
- (no location specified)
Sep 15, 2023
![](/image/sponsor/university_of_campania_"luigi_vanvitelli")
Glucose Metrics After Eating Pizza Margherita in Hybrid Closed
Active, not recruiting
- Type1diabetes
-
Naples, ItalyUniversity of Campania
Feb 6, 2023
Knee Osteoarthritis Trial in Lugano (Blood flow restriction training + Anti-gravity treadmill, Anti-gravity treadmill)
Not yet recruiting
- Knee Osteoarthritis
- Blood flow restriction training + Anti-gravity treadmill
- Anti-gravity treadmill
-
Lugano, SwitzerlandChristian Candrian
Feb 14, 2023
Blood Purification, Dual-cannula, Vena Cava Disconnection Trial (Hemodialysis Catheter)
Not yet recruiting
- Blood Purification
- +2 more
- Hemodialysis Catheter
- (no location specified)
Aug 19, 2022
Lung Ultrasound in Pediatric CAP
Not yet recruiting
- Pneumonia
- lung ultrasound
- (no location specified)
Feb 14, 2023
Metabolic Diseases Trial in Pittsburgh (human hepatocyte transplantation, Preparative Radiation Therapy)
Suspended
- Metabolic Diseases
- human hepatocyte transplantation
- Preparative Radiation Therapy
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of UPMC
Jan 6, 2022
Premature Birth Trial in Oxford
Enrolling by invitation
- Premature Birth
-
Oxford, United KingdomUniversity of Oxford
Jan 16, 2023
Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA
Not yet recruiting
- Adrenal Cortical Carcinoma
- +3 more
- individualized mRNA neoantigen vaccine (mRNA-0523-L001)
-
Shanghai, Shanghai, ChinaRuijin hospital, Shanghai Jiao-Tong University School of Medicin
Nov 19, 2023
Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Japan, United
Recruiting
- Limited Stage Lung Small Cell Carcinoma
- +12 more
- 3-Dimensional Conformal Radiation Therapy
- +7 more
-
Birmingham, Alabama
- +544 more
Aug 24, 2022
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma Trial in Guam,
Recruiting
- Lung Non-Small Cell Carcinoma
- +7 more
- Carboplatin
- +8 more
-
Anchorage, Alaska
- +1084 more
Aug 24, 2022
Dissecting Cellular and Molecular Atlas of Rheumatoid Arthritis
Recruiting
- Rheumatoid Arthritis
- Tapering and/or discontinuation of treatment based on AI-guidance
- +3 more
-
Rome, Italy
- +3 more
Jul 20, 2023
Lymphoma Trial in New York (rituximab, bendamustine, melphalan)
Active, not recruiting
- Lymphoma
- rituximab
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 10, 2023
Early Stage NSCLC Trial in Antwerp, Ghent (hypofractionated radiation therapy followed by surgery)
Terminated
- Early Stage Non-small Cell Lung Cancer
- hypofractionated radiation therapy followed by surgery
-
Antwerp, Belgium
- +1 more
Jul 7, 2021
Parkinson Disease Trial in Stanford (Tactile Stimulation Glove)
Terminated
- Parkinson Disease
- Tactile Stimulation Glove
-
Stanford, CaliforniaStanford University
Nov 22, 2021
Persistent or Recurrent Cutaneous T-Cell Lymphoma Trial in Australia, Puerto Rico, United States (E7777 9 mcg/kg)
Completed
- Persistent or Recurrent Cutaneous T-Cell Lymphoma
- E7777 9 mcg/kg
-
Birmingham, Alabama
- +21 more
Dec 5, 2022